These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16340393)

  • 1. Bradyphrenia and bradykinesia both contribute to altered speech in schizophrenia: a quantitative acoustic study.
    Cannizzaro MS; Cohen H; Rappard F; Snyder PJ
    Cogn Behav Neurol; 2005 Dec; 18(4):206-10. PubMed ID: 16340393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric symptom versus neurocognitive correlates of diminished expressivity in schizophrenia and mood disorders.
    Cohen AS; Kim Y; Najolia GM
    Schizophr Res; 2013 May; 146(1-3):249-53. PubMed ID: 23481582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping schizophrenic negative symptoms onto measures of the patient's speech: set correlational analysis.
    Alpert M; Pouget ER; Welkowitz J; Cohen J
    Psychiatry Res; 1993 Sep; 48(3):181-90. PubMed ID: 8272441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia.
    Alpert M; Shaw RJ; Pouget ER; Lim KO
    J Psychiatr Res; 2002; 36(5):347-53. PubMed ID: 12127603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speech deficits in serious mental illness: a cognitive resource issue?
    Cohen AS; McGovern JE; Dinzeo TJ; Covington MA
    Schizophr Res; 2014 Dec; 160(1-3):173-9. PubMed ID: 25464920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction.
    Fervaha G; Takeuchi H; Foussias G; Agid O; Remington G
    Schizophr Res; 2016 Oct; 176(2-3):411-416. PubMed ID: 27242067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cognitive origins of specific types of schizophrenic speech disturbances.
    Docherty NM; Strauss ME; Dinzeo TJ; St-Hilaire A
    Am J Psychiatry; 2006 Dec; 163(12):2111-8. PubMed ID: 17151162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between information processing and language production.
    Barch D; Berenbaum H
    J Abnorm Psychol; 1994 May; 103(2):241-50. PubMed ID: 8040493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idea density in the life-stories of people with schizophrenia: Associations with narrative qualities and psychiatric symptoms.
    Moe AM; Breitborde NJ; Shakeel MK; Gallagher CJ; Docherty NM
    Schizophr Res; 2016 Apr; 172(1-3):201-5. PubMed ID: 26925799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Symptomatology of speech disorders in schizophrenia in the light of modern research. II].
    Rogovin MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(1):141-6. PubMed ID: 4466224
    [No Abstract]   [Full Text] [Related]  

  • 12. Prosody and lexical accuracy in flat affect schizophrenia.
    Alpert M; Rosenberg SD; Pouget ER; Shaw RJ
    Psychiatry Res; 2000 Dec; 97(2-3):107-18. PubMed ID: 11166083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do people with schizophrenia explain the behaviour of others? A study of theory of mind and its relationship to thought and speech disorganization in schizophrenia.
    Sarfati Y; Hardy-Baylé MC
    Psychol Med; 1999 May; 29(3):613-20. PubMed ID: 10405082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia: The micro-movements perspective.
    Nguyen J; Majmudar U; Papathomas TV; Silverstein SM; Torres EB
    Neuropsychologia; 2016 May; 85():310-26. PubMed ID: 26951932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological impairment in deficit vs. non-deficit schizophrenia.
    Cascella NG; Testa SM; Meyer SM; Rao VA; Diaz-Asper CM; Pearlson GD; Schretlen DJ
    J Psychiatr Res; 2008 Sep; 42(11):930-7. PubMed ID: 18021807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
    Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
    J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurocognitive function in clinically stable patients with schizophrenia or bipolar disorder and normal controls].
    Konstantakopoulos G; Ioannidi N; Patrikelis P; Soumani A; Oulis P; Sakkas D; Papadimitriou GN; Ploumpidis D
    Psychiatriki; 2011; 22(3):195-206. PubMed ID: 21971195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of cognitive and psychomotor functions to the age-related slowing of speech production.
    Rodríguez-Aranda C; Jakobsen M
    J Int Neuropsychol Soc; 2011 Sep; 17(5):807-21. PubMed ID: 21729398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia patients with and without post-traumatic stress disorder (PTSD) have different mood symptom levels but same cognitive functioning.
    Peleikis DE; Varga M; Sundet K; Lorentzen S; Agartz I; Andreassen OA
    Acta Psychiatr Scand; 2013 Jun; 127(6):455-63. PubMed ID: 23176609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alogia and formal thought disorder: differential patterns of verbal fluency task performance.
    Docherty AR; Berenbaum H; Kerns JG
    J Psychiatr Res; 2011 Oct; 45(10):1352-7. PubMed ID: 21555136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.